Novartis Japan Sets Up Special Call Center For Diovan Patients
This article was originally published in PharmAsia News
Amidst the alleged irregularities in clinical trial data regarding the ARB Diovan, Novartis Japan has set up a call center dedicated to helping patients who feel anxious about taking the drug.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.